EVENING EDITION · FRI, JUL 3

FEEDPALS Independent news, aggregated

LIVE WIRE

WORLD — Dashcams are catching it all, but experts say footage alone won't end road rage in Malaysia (Malaymail)POLITICS — 'No feeling to vote': Chinese voters in Johor towns signal reluctance to cast ballots (Malaysiakini)WORLD — 90,000 NGO seleweng dana boleh dibatal pendaftaran (Utusan)WORLD — Bursa Malaysia dijangka terus uji paras 1,700 mata (Utusan)WORLD — Ringgit berpotensi cecah RM4 jika aliran FDI meningkat (Utusan)WORLD — Jangan pandang Kanada sebelah mata (Utusan)TECHNOLOGY — Mi Tuaran bersama ayam char siu (Utusan)WORLD — Perak antara empat negeri atasi pertumbuhan KDNK nasional (Utusan)WORLD — Dashcams are catching it all, but experts say footage alone won't end road rage in Malaysia (Malaymail)POLITICS — 'No feeling to vote': Chinese voters in Johor towns signal reluctance to cast ballots (Malaysiakini)WORLD — 90,000 NGO seleweng dana boleh dibatal pendaftaran (Utusan)WORLD — Bursa Malaysia dijangka terus uji paras 1,700 mata (Utusan)WORLD — Ringgit berpotensi cecah RM4 jika aliran FDI meningkat (Utusan)WORLD — Jangan pandang Kanada sebelah mata (Utusan)TECHNOLOGY — Mi Tuaran bersama ayam char siu (Utusan)WORLD — Perak antara empat negeri atasi pertumbuhan KDNK nasional (Utusan)

Back to feed

Brii Bio Announces Topline End-of-Treatment Data from Phase 2b ENRICH and ENHANCE Studies for the Treatment of Chronic Hepatitis B

End-of-treatment data from ENRICH demonstrated higher HBsAg loss rates, consistent with ENSURE Cohort 4, confirming the role of BRII-179 in priming immune responses for functional cure strategies End-of-treatment data from ENHANCE did not demonstrate improved HBsAg loss rates compared to... The post Brii Bio Announces Topline End-of-Treatment Data from Phase 2b ENRICH and ENHANCE Studies for the Treatment of Chronic Hepatitis B appeared first on Kosmo Digital.

Kosmo Kosmo · Wire Report · Thu, 02 Jul 2026 16:00:00 · 1 min read

Brii Bio Announces Topline End-of-Treatment Data from Phase 2b ENRICH and ENHANCE Studies for the Treatment of Chronic Hepatitis B

Image via wire syndication · Kosmo

WIRE — End-of-treatment data from ENRICH demonstrated higher HBsAg loss rates, consistent with ENSURE Cohort 4, confirming the role of BRII-179 in priming immune responses for functional cure strategies End-of-treatment data from ENHANCE did not demonstrate improved HBsAg loss rates compared to... The post Brii Bio Announces Topline End-of-Treatment Data from Phase 2b ENRICH and ENHANCE Studies for the Treatment of Chronic Hepatitis B appeared first on Kosmo Digital.

"We aggregate wires to encourage regional discovery, sending readers directly back to the original source to explore full coverage."

This is a normalized overview of the breaking feed event. The complete, official release detailing all points, background context, and statements remains hosted by the original publisher.

Read full story at Kosmo